Aktis Oncology Inc Quick Ratio (AKTS) starting from the third quarter 2026 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Aktis Oncology Inc   (NASDAQ: AKTS)
    Sector • Technology    Industry • Consumer Electronics
   Industry • Consumer Electronics
   Sector • Technology

Aktis Oncology Inc 's Quick Ratio

AKTS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 14.02 above Aktis Oncology Inc average.

Within Consumer Electronics industry Aktis Oncology Inc booked the highest Quick Ratio than Aktis Oncology Inc in the third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 145 to 147.

Explain Quick Ratio?
How much Cash & cash equivalents AKTS´s has?
What are AKTS´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AKTS/financial-strength
https://api.csimarket.com/api/v1/companies/AKTS/fundamentals
https://api.csimarket.com/api/v1/companies/AKTS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
AKTS Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q3
(Sep 30 2024)
Q2
Y / Y Current Liabilities Change -61.64 %
Y / Y Cash & cash equivalent Change 3986.97 %
Quick Ratio MRQ 14.02
AKTS's Total Ranking # 147
Seq. Current Liabilities Change 9.44 %
Seq. Cash & cash equivalent Change -48.23 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Consumer Electronics Industry # 1
Technology Sector # 9
Overall Market # 147


Quick Ratio Statistics
High Average Low
62.8 9.12 0.13
(Oct 31 2014)   (Sep 30 2024)




Financial Statements
Aktis Oncology Inc 's Current Liabilities $ 35 Millions Visit AKTS's Balance sheet
Aktis Oncology Inc 's Cash & cash equivalent $ 493 Millions Visit AKTS's Balance sheet
Source of AKTS's Sales Visit AKTS's Sales by Geography


Cumulative Aktis Oncology Inc 's Quick Ratio

AKTS's Quick Ratio for the trailling 12 Months

AKTS Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth -43.98 %
Y / Y Cash & cash equivalent TTM Growth 4174.64 %
Quick Ratio TTM 17.87
Total Ranking TTM # 748
Seq. Current Liabilities TTM Growth -31.35 %
Seq. Cash & cash equivalent TTM Growth 27.8 %


On the trailing twelve months basis AKTS Cash & cash equivalent more than doubled by 3986.97 % in Q3 2026 year on year, while Current Liabilities rose to $35 millions, this led to increase in in Aktis Oncology Inc 's Quick Ratio to 17.87, above AKTS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Consumer Electronics industry 42 other companies have achieved higher Quick Ratio than Aktis Oncology Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2810 to 3531.

Explain Quick Ratio?
How much Cash & cash equivalents AKTS´s has?
What are AKTS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Consumer Electronics Industry # 43
Technology Sector # 576
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
11.44 5.97 0.26
(Sep 30 2019)   (Jun 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Consumer Electronics Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Aktis Oncology Inc   14.02 $ 492.929  Millions$ 35.161  Millions
Unusual Machines Inc   4.44 $ 45.000  Millions$ 10.143  Millions
Satellogic Inc   4.12 $ 106.545  Millions$ 25.879  Millions
Blacksky Technology Inc  3.76 $ 212.219  Millions$ 56.367  Millions

Date modified: 2026-11-13T08:44:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.